Last year, we extended our advisory portfolio to address the scientific needs of our clients, in order to provide immediate value to their R&D labs. Today, we are excited to announce that we have once again been selected for an engagement with a research-driven pharmaceutical company to provide computational drug design services. “This will cover the full spectrum of methods in this space, ranging from quantum mechanics to large macromolecular simulations”, says Dr. Leonard Henkes, Senior Advisor for Computational Chemistry at inhive, “We will assess receptor-ligand interactions and identify the next hit.”
This is an important factor in speeding up drug development efforts; to ultimately deliver better medicines to patients.
Computational Drug Design By Inhive
